- Home
- PMVP vs SER Comparison
PMVP vs SER Comparison
Compare PMVP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMVP
- SER
- Stock Information
- Founded
- PMVP 2013
- SER 2017
- Country
- PMVP United States
- SER United States
- Employees
- PMVP N/A
- SER N/A
- Industry
- PMVP Medicinal Chemicals and Botanical Products
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- PMVP Health Care
- SER Health Care
- Exchange
- PMVP Nasdaq
- SER Nasdaq
- Market Cap
- PMVP 55.1M
- SER 56.5M
- IPO Year
- PMVP 2020
- SER 2018
- Fundamental
- Price
- PMVP $1.09
- SER $5.85
- Analyst Decision
- PMVP Strong Buy
- SER Strong Buy
- Analyst Count
- PMVP 1
- SER 1
- Target Price
- PMVP $5.00
- SER $11.00
- AVG Volume (30 Days)
- PMVP 362.7K
- SER 17.8K
- Earning Date
- PMVP 08-07-2025
- SER 08-08-2025
- Dividend Yield
- PMVP N/A
- SER N/A
- EPS Growth
- PMVP N/A
- SER N/A
- EPS
- PMVP N/A
- SER N/A
- Revenue
- PMVP N/A
- SER $51,000.00
- Revenue This Year
- PMVP N/A
- SER N/A
- Revenue Next Year
- PMVP N/A
- SER N/A
- P/E Ratio
- PMVP N/A
- SER N/A
- Revenue Growth
- PMVP N/A
- SER N/A
- 52 Week Low
- PMVP $0.81
- SER $3.81
- 52 Week High
- PMVP $1.82
- SER $12.69
- Technical
- Relative Strength Index (RSI)
- PMVP 61.16
- SER 50.74
- Support Level
- PMVP $1.01
- SER $5.78
- Resistance Level
- PMVP $1.12
- SER $6.30
- Average True Range (ATR)
- PMVP 0.07
- SER 0.35
- MACD
- PMVP 0.01
- SER -0.03
- Stochastic Oscillator
- PMVP 64.00
- SER 36.74
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.